The Effects of Cognitive – Behavior Therapy and Drug Therapy on Quality of Life and Symptoms of Patients with Irritable Bowel Syndrome

Abstract: Background & Aims: Psychological treatment and the efficacy of drug therapy are considered to be useful in quality of life and symptoms of patients with irritable bowel syndrome. The aim of this study was to examine the effects of cognitive-behavior therapy associated with drug therapy in comparison to drug therapy alone on the quality of life and symptoms of IBS patients with diarrhea predominance. Method: This study was a randomized clinical trial on 64 IBS patients. The patients were selected according to Rome-III criteria, and were divided into the two groups. Bowel Symptoms Severity and Frequency Scale (BSS-FS) and Quality Of Life (QOL-IBS) were used for evaluation of patients’ symptoms. The first group underwent cognitive-behavior therapy with medication therapy, and the second group only received medication. Data were analyzed using analysis of multiple covariances (MANCOVA). Results: The two groups showed significant difference in the QOL-IBS in post treatment and follow-up stages (P 0.05). Conclusion: Cognitive-behavior therapy associated with drug therapy can be useful in IBS patients with diarrhea predominance. However, stopping this treatment may lead to recurrence of the symptoms. Keywords: Neck muscles, Forward head posture, Craniovertebral angle, Electromyography, Pressure Bio-feedback devic

Biological Evaluation of a Novel Tissue Engineering Scaffold of Layered Double Hydroxides (LDHs)

Bone Tissue Engineering (BTE) Composed of Three Main Parts: Scaffold, Cells and Signaling Factors. Several Materials and Composites Are Suggested as a Scaffold for BTE. Biocompatibility is One of the Most Important Property of a BTE Scaffold. in This Work Synthesis of a Novel Nanocomposite Including Layered Double Hydroxides (LDH) and Gelatin is Carried Out and its Biological Properties Were Studied. the Co-Precipitation (PH=11) Method Was Used to Prepare the LDH Powder, using Calcium Nitrate, Magesium Nitrate and Aluminum Nitrate Salts as Starting Materials. the Resulted Precipitates Were Dried. X-Ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM) Analyses Were Used to Characterize the Synthesized Powders. the Results Demonstrated the Presence of Nanocrystals of Ca-LDH and Mg-LDH as Hexagonal and Layered Morphology. the Obtained Powders Were Composed to Gelatin Via Solvent Casting Method Then Freez Dried. the Scaffold Was Prepared Via Membrane Lamination Method from the Resulted Layers that Linked Together with Gelatin as Binder. in Order to Investigate the Scaffold Cytotoxicity MTT Assay Was Done with a Osteosarcoma Cell Line. No Toxic Response Was Observed in Specimens. as a Major Result, It Was Demonstrated that the Specimen Showed a Significant Cellular Response. Then Osteosarcoma Cells Were Cultured for 7-Day and 14-Day Extract of Powders. the Composites Osteoconductivity Was Investigate with Cells Alkaline Phosphatase Extraction. the Results Demonstrated that the Ca-LDH/gelatin Composite Scaffold Has a Good Potential for Bone Tissue Engineering Applications and Mg-LDH Specimen Has a Better Osteconductivity. © (2012) Trans Tech Publications

The serum zinc concentration as a potential biological marker in patients with major depressive disorder

Despite many clinical trials assessing the role of zinc in major depressive disorder (MDD), the conclusions still remain ambiguous. The aim of the present clinical study was to determine and comparison the zinc concentration in the blood of MDD patients (active stage or remission) and healthy volunteers (controls), as well as to discuss its potential clinical usefulness as a biomarker of the disease. In this study 69 patients with current depressive episode, 45 patients in remission and 50 controls were enrolled. The zinc concentration was measured by electrothermal atomic absorption spectrometry (ET AAS). The obtained results revealed, that the zinc concentration in depressed phase were statistically lower than in the healthy volunteers [0.89 vs. 1.06 mg/L, respectively], while the zinc level in patients achieve remission was not significantly different from the controls [1.07 vs. 1.06 mg/L, respectively]. Additionally, among the patients achieve remission a significant differences in zinc concentration between group with and without presence of drug-resistance in the previous episode of depression were observed. Also, patients in remission demonstrated correlation between zinc level and the average number of depressive episodes in the last year. Serum zinc concentration was not dependent on atypical features of depression, presence of psychotic symptoms or melancholic syndrome, age, age of onset or duration of disease, number of episodes in the life time, duration of the episode/remission and severity of depression measured by the Hamilton Rating Scale for Depression (HDRS), and the Montgomery-Asberg Depression Rating Scale (MADRS). Concluding, our findings confirm the correlation between zinc deficit present in the depressive episode, and are consistent with the majority of previous studies. These results may also indicate that serum zinc concentration might be considered as a potential biological marker of MDD

αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans

Although addiction develops in a considerable number of regular cocaine users, molecular risk factors for cocaine dependence are still unknown. It was proposed that establishing drug use and memory formation might share molecular and anatomical pathways. Alpha-Ca(2+)/calmodulin-dependent protein kinase-II (αCaMKII) is a key mediator of learning and memory also involved in drug-related plasticity. The autophosphorylation of αCaMKII was shown to accelerate learning. Thus, we investigated the role of αCaMKII autophosphorylation in the time course of establishing cocaine use-related behavior in mice. We found that αCaMKII autophosphorylation-deficient αCaMKII(T286A) mice show delayed establishment of conditioned place preference, but no changes in acute behavioral activation, sensitization or conditioned hyperlocomotion to cocaine (20 mg kg(-1), intraperitoneal). In vivo microdialysis revealed that αCaMKII(T286A) mice have blunted dopamine (DA) and blocked serotonin (5-HT) responses in the nucleus accumbens (NAcc) and prefrontal cortex after acute cocaine administration (20 mg kg(-1), intraperitoneal), whereas noradrenaline responses were preserved. Under cocaine, the attenuated DA and 5-HT activation in αCaMKII(T286A) mice was followed by impaired c-Fos activation in the NAcc. To translate the rodent findings to human conditions, several CAMK2A gene polymorphisms were tested regarding their risk for a fast establishment of cocaine dependence in two independent samples of regular cocaine users from Brazil (n=688) and Switzerland (n=141). A meta-analysis across both samples confirmed that CAMK2A rs3776823 TT-allele carriers display a faster transition to severe cocaine use than C-allele carriers. Together, these data suggest that αCaMKII controls the speed for the establishment of cocaine's reinforcing effects

Carbon nanotubes part II: A remarkable carrier for drug and gene delivery

Introduction: Carbon nanotubes (CNT) have recently been studied as novel and versatile drug and gene delivery vehicles. When CNT are suitably functionalized, they can interact with various cell types and are taken up by endocytosis.Areas covered: Anti-cancer drugs cisplatin and doxorubicin have been delivered by CNT, as well as methotrexate, taxol and gemcitabine. The delivery of the antifungal compound amphotericin B and the oral administration of erythropoietin have both been assisted using CNT. Frequently, targeting moieties such as folic acid, epidermal growth factor or various antibodies are attached to the CNT-drug nanovehicle. Different kinds of functionalization (e.g., polycations) have been used to allow CNT to act as gene delivery vectors. Plasmid DNA, small interfering RNA and micro-RNA have all been delivered by CNT vehicles. Significant concerns are raised about the nanotoxicology of the CNT and their potentially damaging effects on the environment.Expert opinion: CNT-mediated drug delivery has been studied for over a decade, and both in vitro and in vivo studies have been reported. The future success of CNTs as vectors in vivo and in clinical application will depend on achievement of efficacious therapy with minimal adverse effects and avoidance of possible toxic and environmentally damaging effects. © 2015 Informa UK, Ltd